Clindamycin Injection Dosing
For adults with serious infections, administer clindamycin 600 mg IV every 8 hours, with escalation to 900 mg every 6-8 hours for severe or life-threatening infections; for pediatric patients, use 10-13 mg/kg/dose IV every 6-8 hours, not exceeding 40 mg/kg/day total. 1, 2, 3
Adult Dosing by Infection Severity
Standard Serious Infections
- 600 mg IV every 8 hours is the recommended dose for most serious bacterial infections, including complicated skin and soft tissue infections, MRSA infections, pneumonia, and bone/joint infections 1, 2, 3
- This dosing supersedes older FDA labeling and is based on superior clinical outcomes demonstrated in IDSA guidelines 1
Severe or Life-Threatening Infections
- 900 mg IV every 6-8 hours should be considered for severe infections, necrotizing fasciitis, streptococcal toxic shock syndrome, and mixed anaerobic infections 1, 3
- For pelvic inflammatory disease specifically, use 900 mg IV every 8 hours, typically combined with gentamicin 1, 2, 4
Pediatric Dosing
Standard Dosing for Serious Infections
- 10-13 mg/kg/dose IV every 6-8 hours for MRSA infections, pneumonia, bacteremia, and complicated skin/soft tissue infections 1, 2, 3
- Maximum total daily dose: 40 mg/kg/day regardless of indication 1, 2, 3
Pathogen-Specific Considerations
- For Group A Streptococcal infections requiring IV therapy: 40 mg/kg/day divided every 6-8 hours 1, 2
- For Streptococcus pneumoniae infections: 40 mg/kg/day every 6-8 hours 1
Duration and Transition Strategy
IV to Oral Transition
- Continue IV therapy for at least 48 hours after clinical improvement before transitioning to oral therapy 1, 2
- Oral dosing for adults: 300-450 mg every 6-8 hours 1, 3
- Oral dosing for pediatrics: 30-40 mg/kg/day divided into 3-4 doses 1, 2, 3
Total Treatment Duration
- 7-14 days for most skin and soft tissue infections, with 7 days sufficient for uncomplicated cases 1, 3
- 7-21 days for pneumonia, depending on extent of infection 1, 2, 3
- 2-6 weeks for bacteremia and endocarditis, depending on source and presence of endovascular infection 1, 2, 3
- Minimum 8 weeks for osteomyelitis 1, 2, 3
Critical Combination Therapy Indications
When to Add Second Agent
- Pelvic inflammatory disease: Combine with gentamicin (loading dose 2 mg/kg, then 1.5 mg/kg every 8 hours) 1, 3
- Severe stoma infections with gram-negative involvement: Combine with gentamicin 5-7 mg/kg every 24 hours 1, 3
- Necrotizing fasciitis/streptococcal toxic shock: Combine with penicillin for superior toxin suppression 1
Important Caveats and Pitfalls
Resistance Considerations
- Only use clindamycin when local MRSA clindamycin resistance rates are <10% 1
- Be aware of inducible resistance in erythromycin-resistant MRSA strains 1, 3
Source Control Requirements
- Surgical debridement or drainage is mandatory for abscesses, bone/joint infections, and stoma infections—antibiotics alone are insufficient 1, 3
- If no clinical improvement within 48-72 hours, consider inadequate drainage or deeper infection requiring imaging 1
Contraindications
- Do not use clindamycin if there is concern for infective endocarditis or endovascular source of infection 1
- Can be considered only in children whose bacteremia rapidly clears and is not related to an endovascular focus 1